Challenged: company feels the proposal deals with matters relating to its ordinary business operations & it has substantially implemented the proposal. SEC denied the challenge. 27.37% in favor.
Proposal requests the Board of Directors to commission a third-party report to shareholders analyzing the feasibility of promptly transferring intellectual property and technical knowledge to facilitate the production of COVID-19 vaccine doses by additional qualified manufacturers located in low- and middle-income countries, as defined by the World Bank.
We and selected third parties use cookies or similar technologies for technical purposes and, with your consent, for other purposes. You can consent to the use of such technologies by using the “Accept” button, by closing this notice, by scrolling this page, by interacting with any link or button outside of this notice or by continuing to browse otherwise.